Skip to content

Cognitive and Neural Assessment Platform and Localized Norm for Macau Older Adults.

Establishing Cognitive and Neural Assessment Platform and Localized Norm for Macau Older Adults

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06239922
Enrollment
300
Registered
2024-02-02
Start date
2024-02-29
Completion date
2026-12-30
Last updated
2024-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging, Cognition Disorders in Old Age, Cognitive Change, Cognitive Decline, Cognitive Dysfunction, Cognitive Impairment

Keywords

Macau, cognitive aging

Brief summary

The current project is dedicated to creating a comprehensive cognitive and neural assessment platform and corresponding norms tailored specifically to the older adults in Macau.

Detailed description

The investigators will establish this assessment platform using a combination of methods, including interviews, surveys, and expert reviews. Steps include adapting existing assessment methods to the Macau context, developing new cognitive and neural tasks, defining standardized procedures, seeking external expert input, conducting pilot tests, and validation processes, and refining both the platform and its accompanying manual.

Interventions

None listed

Sponsors

University of Macau
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Must be a local adult resident of Macau * Age above 50 years for older adult cohort * Younger adults individuals above 18 will be included as control comparators

Exclusion criteria

* History of neurological injury or disease * Current use of medications that affect brain function or blood flow * Contraindications to MRI scanning, such as the presence of an electric/mechanical implant or device (e.g., pacemaker) * Claustrophobia * Body weight over 300 lbs due to weight and physical constraints of the scanner (i.e., bore size limited to 55 cm) * Inability to provide informed consent * Pregnancy * Being under the legal age of adulthood (children) * Incarcerated individuals (prisoners)

Design outcomes

Primary

MeasureTime frameDescription
Normative Data for the Montreal Cognitive Assessment - Chinese (Hong Kong) versionFrom February 2024 to January 2026The MoCA will be administered to derive a normative data set representative of the older adult population in Macau.
Normative Data for the Mini-Mental State Examination (MMSE)From February 2024 to January 2026The MMSE will be administered to derive a normative data set representative of the older adult population in Macau.
Normative Scores for Computerized Neuropsychological TasksFrom February 2024 to January 2026Neuropsychological tasks will be employed to measure selective attention capacity and processing speed in the study cohort. These tasks will provide quantifiable data on the efficiency and accuracy of cognitive processing. The collective performance on these tasks will be used to establish benchmark values - including means, medians, and ranges - that define the normative standards for these cognitive abilities in the population.

Secondary

MeasureTime frameDescription
Neural Activation Patterns During Cognitive Tasks as Revealed by Functional Magnetic Resonance Imaging (fMRI)From February 2024 to January 2026fMRI data will be collected to identify patterns of neural activation associated with cognitive task performance.
Cerebral Hemodynamics Assessed Through Functional Near-Infrared Spectroscopy (fNIRS)From February 2024 to January 2026fNIRS will be employed to measure cerebral blood flow and oxygenation during cognitive tasks.
Electrophysiological Correlates of Cognitive Activity as Measured by Electroencephalography (EEG)From February 2024 to January 2026EEG will be utilized to record the electrical activity of the brain during cognitive tasks. Key outcome metrics will include event-related potentials (ERPs) amplitudes and latencies, with mean values and variability measures reported for the cohort.

Countries

Macau

Contacts

Primary ContactHaoyun ZHANG Assistant Professor
haoyunzhang@um.edu.mo+853 88229212
Backup ContactLEI KEI KEI research assistant, MSc
keikeilei@umac.mo+853 88229198

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026